Proxy completion of EQ-5D in patients with dementia

Quality of Life Research

Volumn 14, Issue 1, 2005, Pages 107-118

  Bryan, S ^a   Hardyman, W ^b   Bentham, P ^c   Buckley, A ^c   Laight, A ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SOCIAL CARE INSTITUTE FOR EXCELLENCE   (United Kingdom)

^c QUEEN ELIZABETH PSYCHIATRIC HOSPITAL   (United Kingdom)

^d Parkview Clinic   (United Kingdom)

Author keywords

Construct validity; Dementia; Proxy; Quality of life

Indexed keywords

ADULT; AGED; ANXIETY; CAREGIVER; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DATA ANALYSIS; DEMENTIA; DEPRESSION; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; PATIENT INFORMATION; PATIENT MOBILITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SELF CARE; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; CAREGIVERS; DEMENTIA; FAMILY; GREAT BRITAIN; HEALTH STATUS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PHYSICIANS; PROXY; QUALITY OF LIFE;

EID: 13844255125     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-004-1920-6     Document Type: Review

References (36)

1. National Institute for Clinical Excellence (NICE). Guidance on the Use of Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. Technology Appraisal Guidance No. 19, 2001.
2. Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3(9).
3. Zimmerman SI, Magaziner J. Methodological issues in measuring the functional status of cognitively impaired nursing home residents: The use of proxies and performance based measures. Alzheimer Disease Assoc Disorders 1994; 8(Suppl. 1): S281-S290.
4. Selai C, Trimble MR. Assessing quality of life in dementia. Aging Mental Health 1999; 3(2): 101-111.
5. Magaziner J. Use of proxies to measure health and functional outcomes in effectiveness research in persons with Alzheimer disease and related disorders. Alzheimer Dis Associ Disorders 1997; (Suppl. 6): 168-174.
6. Rabin R, De Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-343.
7. Coucill W, Bryan S, Bentham P, Buckley A, Laight A. EQ-5D as a measure of health-related quality of life in patients with cognitive impairment: An investigation of inter-rater reliability. In: Badia X, Herdman M, Roset M (eds), 16th Plenary Meeting of the EuroQol Group, Sitges, Spain; Discussion papers, Catalan Institute of Public Health, 6-9th November 1999, pp. 169-188. ISBN84-930842-5-5.
8. Coucill W, Bryan S, Bentham P, Buckley A, Laight A. EQ-5D in dementia: An investigation of inter-rater agreement. Med Care 2001; 39(8): 760-771.
9. Devellis RF. Scale Development - Theory and Applications. Newbury Park, CA: Sage Publications, 1991.
10. Bucks RS, Ashworth D, Wilcock GK, Siegfried K. Assessment of daily living in dementia: Development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25: 113-120.
11. Byrne LMT, Wilson PMA, Bucks RS, Hughes AO, Wilcock GK. The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease. Int J Geriatr Psychiatr 2000; 15: 656-661.
12. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi D, Gornbein J. The Neuropsychiatrie Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
13. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess (Review) 1998; 2(14).
14. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. British J Psychiatr 1982; 140: 566-572.
15. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: A practical method of grading the cognitive state of the patient for the clinician. J Psychiatr Res 1975; 12: 189-198.
16. Lezak, MD. Neuropsychological Assessment. 3rd ed. Oxford University Press, 1995.
17. Selai CE, Trimble M, Rossor M, Harvey RJ. The Quality of Life Assessment Schedule (QOLAS): A new method for assessing quality of life (QOL) in dementia; In: Logsdon R, Albert S (ed), Assessing Quality of Life in Dementia. New York: Springer, 2000: 31-48.
18. Dorman PJ, Wadell F, Slattery J, Dennis M, Sandercock P. Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke 1997; 28(10): 1876-1882.
19. Gorter JW. Anticoagulants in the secondary prevention of stroke. 1999. Thesis University of Utrecht, ISDN: 90-393-2231-7.
20. Coons SJ, Rao S, Keinnninger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17(1): 13-35.
21. Dolan P. Modelling valuations for EuroQol health states. Med Care 1997; 35(11): 1095-1108.
22. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. (DSM-4). Washington, DC: APA, 1994.
23. Connelly MA, Johnson JA, Brown N, Montgomery M, Zuberbuhler P. Development of a disease-specific health-related quality of life instrument for people with cystic fibrosis. Institute of Health Economics Working Paper 00-11, 2000.
24. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
25. Cohen J. Statistical Power Analysis for the Behavioural Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
26. Neumann PJ, Kuntz KM, Leon J, et al. Health utilities in Alzheimer's Disease: A cross sectional study of patients and caregivers. Medical Care 1999; 37(1): 27-32.
27. Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. J Clin Epidemiol 1992; 45: 743-760.
28. Varni JW, Katz ER, Seid M, Quiggins DJL, Friedman-Bender A, Castro CM. The Pediatric Cancer Quality of Life Inventory (PCQL). I. Instrument Development, Descriptive Statistics, and Cross-Informant Variance. J Behav Med 1998; 21(2): 179-204.
29. Seid M, Varni JW, Rode CA, Katz ER. The Pediatric Cancer Quality of Life Inventory: A modular approach to measuring health-related quality of life in children with cancer. Int J Cancer 1999; 12(Suppl): 71-76.
30. Felder-Puig R, Frey E, Sonnleithner G, et al. Eur J Pediatr 2000; 159: 283-288.
31. Varni JW, Seid M, Smith Knight T, Uzark K, Szer IS. The PedsQL™ 4.0 Generic Core Scales: Sensitivity, Responsiveness, and Impact on Clinical Decision-Making 2002; 25 (2): 175-193.
32. Glaser AW, Furlong W, Walker DA, et al. Applicability of the health utilities index to a population of childhood survivors of central nervous system tumours in the UK. Eur J Cancer 1999; 35(2): 256-261.
33. Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH. Health-related quality of life in survivors of tumours of the central nervous system in childhood - a preference-based approach to measurement in a cross-sectional study. Eur J Cancer 1999; 35(2): 248-255.
34. Herjanic B, Reich W. Development of a structured psychiatric interview for children: Agreement between child and parent on individual symptoms. J Abnormal Child Psychol 1997; 25(1): 21-31.
35. Varni JW, Seid M, Kurtin PS. PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations. Med Care 2001; 39(8): 800-812.
36. Glaser AW, Davies K, Walker D, Brazier D. Influence of proxy respondents and mode of administration on health status assessment following central nervous system tumours in childhood. Qual Life Res 1997; 6: 43-53.